We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
Truxima, Ritemvia
Active ingredients
Rituximab
AusPAR Date
Published
Submission Number
PM-2017-00695-1-3
Submission Type
Extension of indication and major variation (new strength)
Decision
Approved